Cointime

Modulus Discovery

company

About

Modulus Discovery is a drug discovery company.

  • 11 - 50

Highlights

Total Funding Amount
¥2.34B
Funding Rounds
1
Investors
2
Investments
2

Details

Last Funding Type
Series C
Last Funding Money Raised
¥2.34B
Industries
Biotechnology,Clinical Trials,Medical,Nursing and Residential Care,Pharmaceutical
Founded date
Aug 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

Modulus Discovery is a private Tokyo-based preclinical stage drug discovery company focused on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets through the use of its cutting-edge computational drug discovery expertise and unique biology insights. The international team at Modulus is comprised of drug design and disease biology experts with previous R&D experience at global pharmaceutical, biotechnology , and computational technology firms.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥2.34B
Modulus Discovery has raised a total of ¥2.34B in funding over 2 rounds. Their latest funding was raised on Mar 1, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 1, 2022 Series C ¥2.34B 2 — — Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Modulus Discovery has made 2 investments. Their most recent investment was on Oct 19, 2020, when Genius Teacher raised $2M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 19, 2020 Genius Teacher
Angel $2M EdTech —
Dec 10, 2019 O4S
Seed $1M Blockchain —

Investors

Number of Lead Investors
Number of Investors
—
2
Modulus Discovery is funded by 2 investors. Green Co-Invest Investment and JAFCO Group are the most recent investors.
Investor Name Lead Investor Funding Round
Green Co-Invest Investment — Series C
JAFCO Group — Series C
Cointime
เนื้อหา
บริษัท